These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 28965630)
1. Expression of dog1 in low-grade fibromyxoid sarcoma: A study of 19 cases and review of the literature. Vallejo-Benítez A; Rodríguez-Zarco E; Carrasco SP; Pereira-Gallardo S; Brugal Molina J; García-Escudero A; Robles Frías A; Marcilla D; González-Cámpora R Ann Diagn Pathol; 2017 Oct; 30():8-11. PubMed ID: 28965630 [TBL] [Abstract][Full Text] [Related]
2. DOG1 Expression in Low-Grade Fibromyxoid Sarcoma: A Study of 11 Cases, With Molecular Characterization. Thway K; Ng W; Benson C; Chapman J; Fisher C Int J Surg Pathol; 2015 Sep; 23(6):454-60. PubMed ID: 26135531 [TBL] [Abstract][Full Text] [Related]
3. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma. Doyle LA; Möller E; Dal Cin P; Fletcher CD; Mertens F; Hornick JL Am J Surg Pathol; 2011 May; 35(5):733-41. PubMed ID: 21415703 [TBL] [Abstract][Full Text] [Related]
4. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement. Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887 [TBL] [Abstract][Full Text] [Related]
5. Primary small intestine mesenteric low-grade fibromyxoid sarcoma with foci of atypical epithelioid whorls and diffuse DOG1 expression: a case report. Huang J; Cohen S; Jour G Diagn Pathol; 2020 Mar; 15(1):23. PubMed ID: 32164724 [TBL] [Abstract][Full Text] [Related]
6. Low-Grade Fibromyxoid Sarcoma of the Head and Neck: A Clinicopathologic Series and Review of the Literature. Cowan ML; Thompson LD; Leon ME; Bishop JA Head Neck Pathol; 2016 Jun; 10(2):161-6. PubMed ID: 26276044 [TBL] [Abstract][Full Text] [Related]
7. DOG1 for the diagnosis of gastrointestinal stromal tumor (GIST): Comparison between 2 different antibodies. Lopes LF; West RB; Bacchi LM; van de Rijn M; Bacchi CE Appl Immunohistochem Mol Morphol; 2010 Jul; 18(4):333-7. PubMed ID: 20571340 [TBL] [Abstract][Full Text] [Related]
8. Abdominopelvic and Retroperitoneal Low-Grade Fibromyxoid Sarcoma: A Clinicopathologic Study of 13 Cases. Ud Din N; Ahmad Z; Zreik R; Horvai A; Folpe AL; Fritchie K Am J Clin Pathol; 2018 Jan; 149(2):128-134. PubMed ID: 29385413 [TBL] [Abstract][Full Text] [Related]
9. Low-grade fibromyxoid sarcoma: Clinical, morphologic and genetic features. Mohamed M; Fisher C; Thway K Ann Diagn Pathol; 2017 Jun; 28():60-67. PubMed ID: 28648941 [TBL] [Abstract][Full Text] [Related]
10. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases. Miettinen M; Wang ZF; Lasota J Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013 [TBL] [Abstract][Full Text] [Related]
11. Low-grade fibromyxoid sarcoma versus low-grade myxofibrosarcoma in the extremities and trunk. A comparison of clinicopathological and immunohistochemical features. Oda Y; Takahira T; Kawaguchi K; Yamamoto H; Tamiya S; Matsuda S; Tanaka K; Iwamoto Y; Tsuneyoshi M Histopathology; 2004 Jul; 45(1):29-38. PubMed ID: 15228441 [TBL] [Abstract][Full Text] [Related]
12. Cytomorphologic findings of low-grade fibromyxoid sarcoma. Mustafa S; VandenBussche CJ; Ali SZ; Siddiqui MT; Wakely PE J Am Soc Cytopathol; 2020; 9(3):191-201. PubMed ID: 32197967 [TBL] [Abstract][Full Text] [Related]
13. DOG1 (clone K9) is seldom expressed and not useful in the evaluation of pancreatic neoplasms. Hemminger J; Marsh WL; Iwenofu OH; Frankel WL Appl Immunohistochem Mol Morphol; 2012 Jul; 20(4):397-401. PubMed ID: 22495382 [TBL] [Abstract][Full Text] [Related]
14. Low-grade Fibromyxoid Sarcoma of the Vulva and Vagina: Clinical, Pathologic, and Molecular Characterization of 7 Cases and Review of the Literature. Costigan D; Dal Cin P; Fletcher CDM; Nucci MR; Parra-Herran C; Chapel DB Am J Surg Pathol; 2022 Sep; 46(9):1196-1206. PubMed ID: 35617488 [TBL] [Abstract][Full Text] [Related]
15. Low-grade fibromyxoid sarcoma of the breast: genetic characterization and immunohistochemical comparison to morphologic mimics. Cloutier JM; Moreland A; Wang L; Kunder CA; Allard G; Wang A; Krings G; Charville GW; Bean GR Hum Pathol; 2023 Sep; 139():17-26. PubMed ID: 37392946 [TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes. Liegl B; Hornick JL; Corless CL; Fletcher CD Am J Surg Pathol; 2009 Mar; 33(3):437-46. PubMed ID: 19011564 [TBL] [Abstract][Full Text] [Related]
18. FUS (16p11) gene rearrangement as detected by fluorescence in-situ hybridization in cutaneous low-grade fibromyxoid sarcoma: a potential diagnostic tool. Patel RM; Downs-Kelly E; Dandekar MN; Fanburg-Smith JC; Billings SD; Tubbs RR; Goldblum JR Am J Dermatopathol; 2011 Apr; 33(2):140-3. PubMed ID: 21399449 [TBL] [Abstract][Full Text] [Related]
19. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors. Espinosa I; Lee CH; Kim MK; Rouse BT; Subramanian S; Montgomery K; Varma S; Corless CL; Heinrich MC; Smith KS; Wang Z; Rubin B; Nielsen TO; Seitz RS; Ross DT; West RB; Cleary ML; van de Rijn M Am J Surg Pathol; 2008 Feb; 32(2):210-8. PubMed ID: 18223323 [TBL] [Abstract][Full Text] [Related]
20. Claudin-1 is expressed in perineurioma-like low-grade fibromyxoid sarcoma. Thway K; Fisher C; Debiec-Rychter M; Calonje E Hum Pathol; 2009 Nov; 40(11):1586-90. PubMed ID: 19540561 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]